After an acute cerebral infarction or a transient ischemic attack (TIA), the risk of another stroke is massively increased. That early treatment with an antiplatelet agent contributes to secondary prevention was demonstrated in the THALES study. Thus, ticagrelor as an add-on to aspirin after an ischemic stroke or TIA resulted in a significant risk reduction for another stroke.